- Home
- CITE vs WW Comparison
CITE vs WW Comparison
Compare CITE & WW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CITE
- WW
- Stock Information
- Founded
- CITE 2021
- WW 1961
- Country
- CITE United States
- WW United States
- Employees
- CITE N/A
- WW N/A
- Industry
- CITE
- WW Other Consumer Services
- Sector
- CITE
- WW Consumer Discretionary
- Exchange
- CITE NYSE
- WW Nasdaq
- Market Cap
- CITE 92.8M
- WW 75.9M
- IPO Year
- CITE 2022
- WW 2001
- Fundamental
- Price
- CITE $11.70
- WW $1.34
- Analyst Decision
- CITE
- WW Buy
- Analyst Count
- CITE 0
- WW 5
- Target Price
- CITE N/A
- WW $3.44
- AVG Volume (30 Days)
- CITE 33.9K
- WW 4.1M
- Earning Date
- CITE 01-01-0001
- WW 11-06-2024
- Dividend Yield
- CITE N/A
- WW N/A
- EPS Growth
- CITE N/A
- WW N/A
- EPS
- CITE N/A
- WW N/A
- Revenue
- CITE N/A
- WW $807,465,000.00
- Revenue This Year
- CITE N/A
- WW N/A
- Revenue Next Year
- CITE N/A
- WW N/A
- P/E Ratio
- CITE N/A
- WW N/A
- Revenue Growth
- CITE N/A
- WW N/A
- 52 Week Low
- CITE $10.86
- WW $0.67
- 52 Week High
- CITE $12.25
- WW $9.77
- Technical
- Relative Strength Index (RSI)
- CITE 60.81
- WW 51.18
- Support Level
- CITE $11.61
- WW $1.34
- Resistance Level
- CITE $11.75
- WW $1.66
- Average True Range (ATR)
- CITE 0.03
- WW 0.19
- MACD
- CITE -0.00
- WW -0.01
- Stochastic Oscillator
- CITE 62.50
- WW 39.68
About CITE CARTICA ACQUISITION CORP
Cartica Acquisition Corp is a blank check company.
About WW WW International Inc.
WW International Inc is a provider of weight loss solutions. The firm offers its members access to in person workshops and digital solutions as a part of its weight loss and weight management programs. Its digital app provides members access to tools such as, trackers for food, water, activity, weight, content regarding behavioral techniques for building healthy habits and other related tools. Along with its in person workshops and digital solutions, the company also provides members who medically qualify access to clinicians who can prescribe weight management medications when clinically appropriate. The company generates majority of its revenue in the form of Subscription Revenue. Geographically, the company generates key revenue from North America and rest from International markets.